Top Searches
Advertisement

NEXT-Level Innovation: Indegene’s GenAI Engine Powers Regulatory Revolution


Updated: July 12, 2025 12:33

Image Source : eHealth Magazine
Indegene has introduced NEXT Medical Writing Automation, a groundbreaking solution that promises to revolutionize how life sciences organizations create regulatory and clinical content. Created by veteran medical writers and driven by Indegene Cortex's inhouse AI engine, NEXT leverages domain expertise and generative AI to automate, enhance compliance, and facilitate strategic intent.
 
Key Highlights of the Launch
  • NEXT streamlines the creation of highquality, regulatorapproved documents throughout clinical development and submissions
  • Works in familiar environments like Microsoft Word, according to sponsorspecific workflows and formats
  • Natively interoperable with Regulatory Information Management (RIM) systems to enable traceability and consistency
Strategic Advantage
  • Automates scheduling and intelligent task assignment
  • It minimizes hand formatting and data handling, enabling thinkers to concentrate on thinking and strategy
  • Enables scalability with a strong compliance core
Industry Impact
  • Adapts with increasing document complexity and regulatory control
  • Positions Indegene at the forefront of AIdriven life sciences transformation
  • Highlights the organization's focus on optimizing commercialization processes for medtech and biopharma clients
Financial Overview
  • Indegene reported a 24.1% growth in net profit at Rs 117.60 crore in Q4 FY25
  • Net sales increased 12.3% to Rs 755.60 crore
  • BSE closed at Rs 564.35, down 1.02% from the previous session
NEXT is not only about robots—it's a strategic driving force behind futureproof medical writing.
 
Sources: Business Standard, Equity Bulls, Indegene.com, SSPL Securities, MedTechNews, Digital Health News

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement